The role of leptin in the etiopathogenesis of anorexia nervosa and bulimia

Eating and Weight Disorders

Volumn 8, Issue 2, 2003, Pages 130-137

  Calandra, C ^a   Musso, F ^a   Musso, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Anorexia; BMI; Bulimia; Humans; Serum leptin levels; Weight reduced controls

Indexed keywords

LEPTIN;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; BULIMIA; COMPARATIVE STUDY; FEMALE; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; BODY MASS INDEX; BODY WEIGHT; BULIMIA; FEMALE; HUMANS; LEPTIN;

EID: 0141782327     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03325002     Document Type: Article

References (39)

1. Becker A.E., Grinspoon S.K., Klibanski A., Herzog D.B.: Eating disorders. N. Engl. J. Med., 340, 1092-1098, 1999.
2. Eiro M, Katoh T. et al.: Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. N. Engl. J. Med., 346, 140, 2002.
3. Zhang Y., Proenca R., et al: Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432, 1994.
4. Campfield L.A., Smith F.J. et al.: Recombinant mouse OB protein; evidence for a peripheral signal linking adiposity and central neural networks. Science, 269, 546-549, 1995.
5. Weigle D.S., Bukowski T.R., Foster D.C., et al: Recombinant ob protein reduces feeding and body weight in the OB/OB mouse. J. Clin. Invest., 96, 2065-2070, 1995.
6. Tartaglia L.A., Dembski M., Weng X., et al: Identification and expression cloning of a leptin receptor, OB-R. Cell, 83, 1263-1271, 1995.
7. Shuldiner A.R., Yang R., et al: Resistin, obesity, and insulin-resistance. The emerging role of the adipocyte as an endocrine organ. N. Engl. J. Med., 345, 1345-1346, 2001.
8. Musso F., Calandra C, Musso R., et al: Evaluation of leptin protein and human thrombopoi-etin levels in patients with anorexia nervosa and bulimia. Hematol. J., 1 (suppl. 1) abstract, 256, 76, 2001.
9. Musso F., Calandra C, Musso R., et al: Relationship of human plasma leptin concentration with blood cell parameters in anorexia nervosa and bulimia patients. Hematol. J., 1 (suppl. 1) abstract, 266, 76, 2001.
10. Ghilardi N., Skoda R.C.: The leptine receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol., 11, 393-399, 1997.
11. Baumann H., Morella K.K., et al: The full length leptin receptor has signalling capabilities of interleukin 6-type receptors. Proc. Natl. Acad. Sci. USA, 93, 8374-8378, 1996.
12. Stephens T.W., Basinski M., Bristow P.K., et al: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530-532, 1995.
13. Baj Y., Zhang S., et al: Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J. Biol. Chem., 271, 13939-13942, 1996.
14. Cohen B., Novick D., Rubinstein M.: Modulation of insulin activities by leptin. Science, 274, 1185-1188, 1996.
15. Gainsford T., Wilson T.A., Metcalf D., et al: Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. USA, 93, 14564-14568, 1996.
16. Shimabukuro M., Koyama K., Chen G., et al: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA, 94, 4637-4641, 1997.
17. Caro J., Sinha M.K., Kolacziynski L.W., Zhang P.L., Considine R.V: Leptin: the tale of an obesity gene. Diabetes, 45, 1455-1462, 1996.
18. Caro J.F., Kolacziynski J.W., Nyce M.R., et al: Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet, 348, 159-161, 1996.
19. Maffei M., Halaas J., Ravussin E., et al: Leptin levels in human and rodent: measurement of plasma leptin and OB RNA in obese and weight-reduced subjects. Nature Med., 1, 1155-1161, 1995.
20. Ahima R.S., Prabakaran D., Mantzoros C, et al: Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250-252, 1996.
21. Thompson F.E., Byers T.: Dietary assessment resources manual. J. Nutr. 124, 2245S-2317S, 1994.
22. Manson J.E., Stampfer M.J., Hennekens C.H., Wille W.C.: Body weight and longevity: a reassessment. JAMA 257, 353-358, 1987.
23. Calle E.E., et al: Body mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med., 341, 1097-1104, 1999.
24. Report of a WHO expert committee: Physical status: the use and interpretation of anthropometry. WHO Tech. Rep. Ser. 854, 1-452, 1995.
25. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM IV) Washington, DC, APA, 1994.
26. Garner D.M.: Professional Manual Eating Disorders Inventory, II Odessa, FL. Psychological assessment resources, 1990.
27. Calandra C, Gulino V. Inserra L., Giuffrida A.: The use of Citalopram in an integrated approach to the treatment of eating disorders: An open study. Eat. Weight Disord., 4, 207-210, 1999.
28. Gendall K. A., Bulik C. M., Sullivan P.F., Joyce P.R., Mcintosh V.V., Carter F.A.: Body weight in bulimia nervosa. Eat. Weight Disord., 4, 157-164, 1999.
29. Eckert E.D., Pommeroy C. et al.: Leptin in anorexia nervosa. J. Clin. Endocrinol. Metab., 83, 791-795, 1997.
30. Hebebrand J., Vanderheyden J., Devos R., et al: Plasma concentration of obese protein in anorexia nervosa. Lancet, 346, 1624-1625, 1995.
31. Grinspoon S., Gullick T., Askari H., et al: Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab., 81, 3861-3863, 1996.
32. Rosenbaum M., Nicolson M., Hirsch J., et al: Effects of gender, body composition and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab., 81, 3424-3427, 1996.
33. Argenté J., Barris V., et al.: Leptin plasma levels in healthy Spanish children and adolescents, children with obesity and adolescents with anorexia and bulimia nervosa. J. Pediatr., 22, 833-838, 1997.
34. Sorbi S., Nacmias B., et al: 5-HT2A promoter polymorphism in anorexia nervosa. Lancet, 351, 1785-1786, 1998.
35. Fulton S., Woodside B., Shizgal P. et al.: Modulation of brain reward circuitry by Leptin. Science, 287, 125-128, 2000.
36. Maffei M., Halaas J., Ravussin E., et al: Leptin levels in human and rodent: measurement of plasma leptin and OB RNA in obese and weight-reduced subjects. Nature Med., 1, 1155-1161, 1995.
37. Halaas J.L., Gajiwala K.S., Maffei M., et al: Weight-reducing effects of the plasma protein encoded by the obese gene. Science, 269, 543-546, 1995.
38. Pelleymounter M.A., Cullen M.J., Baker M.B., et al: Effects of the obese gene product on body weight regulation in the ob/ob mice. Science, 269, 540-543, 1995.
39. Farooqi LS., Jebb S.A., Langmack G., et al: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med., 341, 879-883, 1999.